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Letters to the EditorReference
1. Katayama S, Umetani N, Hisada T, Sugiura S.
Bicuspid aortic valves undergo excessive strain
during opening: a simulation study. J Thorac
Cardiovasc Surg. 2013;145:1570-6.
http://dx.doi.org/10.1016/
j.jtcvs.2013.08.088Reply to the Editor:
I greatly appreciate Dr Bassano and
his colleagues’ interest in our article.1
I read the results of their clinical data
with interest as well. They found a
steep increase in the rate of aortic
expansion at an aortic diameter of 50
mmwith strong statistical significance
even in the analysis on a relatively
small number of patients. This result
is quite different from that of our pre-
vious study in which no significant
correlation was found between preop-
erative aortic diameter and the aortic
expansion rate after aortic valve
replacement (AVR).1 Perhaps these
discordant results may be attributable
to differences in the patient cohorts,
but I believe they need to look back
at their data to see whether any other
plausible factors exist as confounders
(eg, connective tissue disorder)
behind their correlation.
There have been mixed conclusions
in the literature on whether to replace
amoderately dilated aorta or not during
AVR, and controversies are ongoing.2-4
Our previous study showed that AVR
alone seemed reasonable in a
moderately dilated ascending aorta
based on a low rate of clinical events
and aortic aneurysm formation as well
as the limited rate of aortic expansion,
but the study was not meant to be
conclusive; its results were believed to
be provocative of further studies to
define a more reasonable indication
for concomitant replacement of the
aorta. Safety in concomitant aortic
surgery is another issue to be
addressed. Although there was no
operative mortality among 70 patients
who underwent aorta replacement in
our series, I don’t agree that it can
be performed ‘‘without significant1440 The Journal of Thoracic andadditional risks.’’ Evaluations on tens
of patients are not enough to
determine the risk of a procedure, and
I believe that any additional procedure
always carries a certain level of risk.
What is important is how great the
risk is. Current risk calculating
systems for cardiovascular surgery,
EuroSCORE II for instance, also
consider this ‘‘additional procedure’’
as the factor that increases early
mortality calculated in a logistic
function. Because a dilated aorta is a
common finding during AVR, the
recommendations we make may
affect a huge number of patients, even
if the increased risk of concomitant
aorta surgery is small. Thus, risk-
benefit assessments on concomitant
aorta surgery should be made through
large-scale studies such asmultiinstitu-
tional registry-based analyses.
We found that the rate of aortic
expansion was 5.6  8.0 mm/y in
aortic stenosis, 2.6  5.2mm/y in
mixed stenoregurgitation, and 1.4
 4.5 mm/y in aortic regurgitation;
the differences were statistically
marginal as shown in our previous
study (P ¼ .083 using the Kruskal-
Wallis test).1 When we compared the
expansion rates only between aortic
stenosis and aortic regurgitation, the
difference was statistically significant
(P ¼ .003 using the Mann-Whitney U
test), in concordance with Dr Bassano
and colleagues’ assumption. This is an
unexpected finding in my view, and
Dr Bassano’s hypothesis may explain
the mechanism behind this phenome-
non, but other plausible mechanisms
can be speculated as well. Further
studies are also needed to address
this issue, and I believe the study
population should be extended to
those with all sizes of aorta rather
than confining it to a certain range to
reach an appropriate conclusion on
this.
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j.jtcvs.2013.12.035Reply to the Editor:
We appreciate much the interest in
our report.1 The issues raised by
this letter can be summarized as
follows: (1) what was the etiology
of the tricuspid regurgitation (TR);
(2) what was the pulmonary artery
pressure (PAP) level; and (3) whether
TR associated with a left-sided car-
diac lesion will exhibit a poorer
prognosis?
With regard to the etiology of TR,
8 patients had a history of blunt
chest trauma, all of whom showed
leaflet prolapse. For these patients,
the etiology would probably fit into
‘‘traumatic’’ but that might not be
confirmative. Another 12 patients
had leaflet prolapse; however, a his-
tory of chest trauma was not evident.
This could have been, in part, because
some patients might not recall the
traumatic event that happened long
ago. Although the etiology, in these
cases, could have been degenerative
or traumatic, it would be better for it
to remain as ‘‘unknown.’’ Regarding
rheumatic involvement, the presence
